SOX2-RELATED MICRORNAS AS PROGNOSTIC MARKERS OF RECURRENCE IN SURGICALLY TREATED NON-SMALL-CELL LUNG CANCER (NSCLC)

被引：0
|
作者：
Navarro, Alfons [1 ]
Campayo, Marc [2 ]
Vinolas, Nuria [2 ]
Ciria, Victor [1 ]
Diaz, Tania [1 ]
Marrades, Ramon [2 ]
Ramirez, Jose [2 ]
Gimferrer, Jose M. [2 ]
Monzo, Mariano [1 ]
Molins, Laureano [2 ]
机构：
[1] Univ Barcelona, E-08007 Barcelona, Spain
[2] Hosp Clin Sao Paulo, Sao Paulo, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
miR-367; NSCLC; miR-145; SOX2;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1062 / S1062
页数：1
相关论文
共 50 条
  • [41] Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer
    Dirk Hellwig
    Andreas Gröschel
    Thomas P. Graeter
    Anne P. Hellwig
    Ursula Nestle
    Hans-Joachim Schäfers
    Gerhard W. Sybrecht
    Carl-Martin Kirsch
    European Journal of Nuclear Medicine and Molecular Imaging, 2006, 33 : 13 - 21
  • [42] Sarcopenia: an unneglectable nutritional status for patients with surgically treated non-small-cell lung cancer Reply
    Sun, Changbo
    Anraku, Masaki
    Nakajima, Jun
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2019, 56 (02) : 420 - 421
  • [43] Identification of Prognostic Markers of N6-Methylandenosine-Related Noncoding RNAs in Non-Small-Cell Lung Cancer
    Zhang, Zexin
    Li, Jing
    Lu, Ke
    Wu, Wenfeng
    Huang, Ziyi
    Zhang, Chi
    Guo, Wei
    Li, Jiayin
    Lin, Lizhu
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [44] Plasma microRNAs as potential biomarkers for non-small-cell lung cancer
    Shen, Jun
    Todd, Nevins W.
    Zhang, Howard
    Yu, Lei
    Lingxiao, Xing
    Mei, Yuping
    Guarnera, Maria
    Liao, Jipei
    Chou, Amy
    Lu, Changwan Larry
    Jiang, Zhengran
    Fang, HongBin
    Katz, Ruth L.
    Jiang, Feng
    LABORATORY INVESTIGATION, 2011, 91 (04) : 579 - 587
  • [45] Circulating endothelial cells and microparticles as prognostic markers in advanced non-small-cell lung cancer
    Fleitas, Tania
    Martinez-Sales, Vicenta
    Vila, Virtudes
    Reganon, Edelmiro
    Mesado, David
    Martin, Maria
    Gomez-Codina, Jose
    Montalar, Joaquin
    Reynes, Gaspar
    THROMBOSIS RESEARCH, 2012, 130 : S200 - S200
  • [46] Prognostic and predictive markers for personalized adjuvant therapy for non-small-cell lung cancer patients
    Gadgeel, Shirish M.
    Bepler, Gerold
    FUTURE ONCOLOGY, 2013, 9 (12) : 1909 - 1921
  • [47] CEA response as a prognostic marker in non-small-cell lung carcinoma (NSCLC) patients treated with gefitinib or erlotinib
    Ceballos, J.
    Lopez-Picazo, J.
    Reyna, C.
    Moreno Jimenez, M.
    Perez-Gracia, J. L.
    Ponz Sarvise, M.
    Olier, C.
    Gil Bazo, I.
    Gurpide, A.
    Garcia-Foncillas, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [48] The Role of the Selected miRNAs as Diagnostic, Predictive and Prognostic Markers in Non-Small-Cell Lung Cancer
    Szczyrek, Michal
    Bitkowska, Paulina
    Jutrzenka, Marta
    Milanowski, Janusz
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (08):
  • [49] TARGETING MEK AND BRAF IN NON-SMALL-CELL LUNG CANCER (NSCLC)
    Planchard, D.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S23 - S23
  • [50] ALK-rearrangement in non-small-cell lung cancer (NSCLC)
    Du, Xue
    Shao, Yun
    Qin, Hai-Feng
    Tai, Yan-Hong
    Gao, Hong-Jun
    THORACIC CANCER, 2018, 9 (04) : 423 - 430
12345